Bristol Myers Squibb Co. stock outperforms competitors on strong trading day
Shares of Bristol Myers Squibb Co. BMY rose 3.67% to $57.88 Monday, on what proved to be an all-around mixed trading session ...
Bristol Myers CEO bought $110K in common stock
In a regulatory filing on Friday night, Bristol Myers (BMY) disclosed that its CEO Christopher Boerner bought 2K shares of common stock on ...
FDA accepts Bristol Myers’ sBLA for Opdivo plus Yervoy
Squibb announced that the U.S. FDA has accepted the supplemental biologics license application for Opdivo plus Yervoy as a ...
$1.3M Settlement: Focus Groups Helped Craft the Deal
The case was made more complex because the plaintiff, who was 36 at the time of the crash, had prior back problems.
His Back Injured In Crash, Man Agrees to $1.3M Settlement
The case was made more complex because Gosinanonth, who was 36 at the time of the crash, had prior back problems, Hall said.
Bristol Myers Squibb Co. stock underperforms Wednesday when compared to competitors despite daily gains
This was the stock's second consecutive day of gains.
Barron's5d
Bristol Myers Squibb Co.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...